References
-
1.
Ades S, Pulluri B, Holmes CE, Lal I, Kumar S, Littenberg B. Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER-Medicare analysis. Cancer Med. 2022;11(8):1817-26. [PubMed ID: 35129311]. [PubMed Central ID: PMC9041082]. https://doi.org/10.1002/cam4.4581.
-
2.
Rees PA, Clouston HW, Duff S, Kirwan CC. Colorectal cancer and thrombosis. Int J Colorectal Dis. 2018;33(1):105-8. [PubMed ID: 29127473]. [PubMed Central ID: PMC5748414]. https://doi.org/10.1007/s00384-017-2909-2.
-
3.
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110(10):2339-46. [PubMed ID: 17918266]. https://doi.org/10.1002/cncr.23062.
-
4.
Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N, et al. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica. 2019;104(6):1277-87. [PubMed ID: 30606788]. [PubMed Central ID: PMC6545838]. https://doi.org/10.3324/haematol.2018.209114.
-
5.
Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol. 2006;24(7):1112-8. [PubMed ID: 16505431]. https://doi.org/10.1200/JCO.2005.04.2150.